Altered expression of COX-2 and TNF-alfa in patients with hepatocellular carcinoma
Rev. esp. enferm. dig
; 111(5): 364-370, mayo 2019. ilus, tab, graf
Article
in En
| IBECS
| ID: ibc-189989
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
Background and aim:
hepatocellular carcinoma is a type of cancer related with inflammation, as 90% of cases develop in a chronic inflammation condition. Excess inflammation can affect tissue homeostasis. Cytokines and inflammatory mediators are immunological components that can influence the functioning of cells and tissues. In addition, the estrogen receptor appears to play an important role in hepatocarcinogenesis. The aim of the study was to evaluate the expression of inflammatory markers and ER in patients with hepatocellular carcinoma.Methods:
data from 143 patients of ISCMPA were analyzed. Immunohistochemistry was performed of cyclooxygenase-2 enzyme (COX-2), nuclear factor kappa B (NF-κB), tumor necrosis factor alpha (TNF-alfa) and ER in paraffin-embedded hepatic tissue. The percentage of the stained area, intensity of staining and of the number of ER positive nuclei were evaluated using the ImageJ 1.50 software. Results andconclusion:
there was a significant difference between the groups in terms of the percentage of marked area (p = 0.040) for COX-2 and the intensity of staining of TNF-alfa (p = 0.030). No significant differences were observed in any of other parameters evaluated. In conclusion, COX-2 and TNF-alfa are possible markers that should be further studied to determine their immunohistochemical profile and role in HCC developmentRESUMEN
No disponible
Search on Google
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Tumor Necrosis Factor-alpha
/
Carcinoma, Hepatocellular
/
Cyclooxygenase 2
/
Liver Neoplasms
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Rev. esp. enferm. dig
Year:
2019
Document type:
Article